Human Embryo's First Genetic Stirrings Felt
Sep 04
|
GEN News | Researchers at the Karolinska Institutet have measured the RNA expression of pre-implantation fertilized embryos to learn which genes are activated in the first days of human development.
more
August News and Product Briefs
Sep 03
|
Bio-IT World | News and product briefs from around the industry, including new types of data for the Genome in a Bottle Consortium and prizes for rare disease research.
more
Intel Joins Up with Cancer Centers to Build Secure Networks for Patient Data Sharing
Sep 02
|
Bio-IT World | The Collaborative Cancer Cloud, a collaborative effort of Intel, the Knight Cancer Center, and two additional partners, will be a secure, open source system for sending large queries between clinical data centers, making it possible to share data for research and patient care while minimizing the volume of data transferred and the associated patient privacy concerns.
more
Punctuating Messages Encoded in Human Genome with Transposable Elements
Aug 04
|
SAN FRANCISCO, CA, UNITED STATES - Aug 4, 2015 - Since the classical studies of Jacob and Monod in the early 1960s, it has been evident that genome sequences contain not only blueprints for genes and the proteins that they encode, but also the instructions for a coordinated regulatory program that governs when, where and to what extent these genes and proteins are expressed
more
Creative Bioarray Introduces Whole Chromosome Painting Probes to Biological Researchers
Jul 20
|
NEW YORK, NY - Jul 20, 2015 - Creative Bioarray, an innovative biotechnology company who supplies research-use cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services, etc, has announced its Whole Chromosome Painting Probes to bio-research community
more
As data volumes grow and scientific advances require more compute power, life sciences organizations need more powerful, lower-cost solutions to meet demand. IBM Software Defined Infrastructure (SDI) featuring IBM® Platform Computing™ helps clients increase their competitive advantage by using an agile, high-performance, shared infrastructure resulting in faster time-to-results for analytics and collaboration across the research and development ecosystem.
IBM® is a global technology company that develops and sells software and systems including a broad range of infrastructure, IBM SoftLayer®cloud and consulting services in more than 170 countries. Along with its life sciences industry partners, IBM enables its clients to accelerate time-to-value with powerful IBM Power® and storage systems designed to accelerate and optimize life science workloads.
Exxact Certified Life Science GPU Systems
Exxact designs a series of certified life science GPU systems in collaboration with life science software developers to provide value-add turnkey solutions for optimizing the scientific workflow and accelerating the pace of research. Each system is ready to run out of the box and capable of accelerating complex bioscience codes, in fields encompassing, drug discovery, biocatalyst design, molecular biology, bioinformatics and materials science.
Product Highlights:
- Validated by App Developers
- Out-of-box Performance
- Support and Consultation
- Fully Customizable
Visit http://www.exxactcorp.com/newproducts/Certified-Life-Science-GPU-Systems to learn more about the certified life science systems and case study.
|
|
Data Integration in Life Science – Are You Ready? |
Thu, May 1 at 1 pm EST | Sponsored by YarcData
Ready...Set...Collaborate--Saving Millions with Faster Time to Market |
Thu, May 15 at 11 am EST | Sponsored by Exostar
Redefining Targeted Sequencing: Complete Coverage of Targeted Regions via an Innovative Massively-Parallel Singleplex PCR Enrichment |
Wed, May 28 at 1 pm EST | Sponsored by Wafergen
Genome-Phenome Analysis |
Wed, June 25 at 1 pm EST | Sponsored by SimulConsult
How TGen is Applying High Performance Computing to Accelerate Cancer Research
Sponsored by Terascala
An Integrated Platform for All Translational Medicine Data: Using Visual Analytics and Tibco Spotfire to Enhance Personalized Medicine and Translational Science
Sponsored by PerkinElmer
Trends in BioIT Data Management & Storage
Sponsored by Avere Systems
Big Bioinformatics and Healthcare Analytics without Big Hassles
Sponsored by Paradigm4
Manage Complexity by Visual Data Exploration
Sponsored by Qlucore
Digital Signatures in the Enterprise
Sponsored by ARX
Complete Webinar Listing
Bio-IT World Conference & Expo
April 29- May 1, 2014 • Boston, MA
BIOtech 2014 in Japan
May 14-16, 2014 • Tokyo, Japan
2nd Annual Next Generation Sequencing Data Congress
May 19-20, 2014 • London, UK
14th Annual Structure-Based Drug Design
May 21-22, 2014 • Boston, MA
15th Annual Drug Discovery Leaders Summit 2014
June 2-3, 2014 • Geneva, Switzerland
6th Annual Drug Development Congress 2014
June 2-3, 2014 • Geneva, Switzerland
2nd Annual Discovery Chemistry & Drug Design Congress 2014
June 2-3, 2014 • Geneva, Switzerland
Conference on Translational Medicine
September 22-25, 2014 • Vienna, Austria
4th Annual Next Generation Sequencing Asia Congress 2014
October 7-8, 2014 • Singapore
2nd Annual Single Cell Genomics & Transcriptomics Asia Congress 2014
October 7-8, 2014 • Singapore
6th Annual Next Generation Sequencing Congress 2014
November 2014 • UK
Complete Event Listing
|
New! Bio-IT World now offers free eBooks
available for download. These eBooks are a compilation of the "best
of" stories on a series of pressing topics within bio IT and drug
discovery.
|
April 9, 2013 • Bio-IT World Conference & Expo
April 24, 2012 • Bio-IT World Conference & Expo
February 6, 2012 • SCOPE Summit
April 24, 2012 • Bio-IT World Conference & Expo
January 12, 2012 • Peptalk
View More DVDs
 |
BIOVIA’s ScienceCloud |
|
| |
The BIOVIA Biologics Solution |
Less Searching, More Knowing: Game-Changing Advancements in Pharmacovigilance and Regulatory Intelligence November 13 at 11am EST | Register Today to Reserve Your Space Sponsored by It is no surprise that authors place what they consider to be their most important and promising findings into an abstract. But as an abstract’s size
|
|
|